Dedicated Support to Help You Get Your ACTEMRA for GCA Treatment
It is important for you to get the ACTEMRA your doctor prescribed.
Genentech has programs that can help based on your unique needs. If you:
Need help understanding insurance coverage and costs: ACTEMRA Access Solutions
- ACTEMRA Access Solutions works with your doctor, health insurance company and specialty pharmacy to help you get your ACTEMRA
Do not have insurance coverage or your insurance doesn't cover enough of the cost of your ACTEMRA: Genentech Patient Foundation
- The Genentech Patient Foundation gives you your ACTEMRA for free if you're eligible*
Have insurance and need help paying for ACTEMRA: Affordability Options
- The ACTEMRA Co-pay Program may help you pay as little as $5 per prescription† with up to $15,000 in co-pay support annually for eligible, commercially insured patients.‡
†The final amount owed by patients may be as little as $5, but may vary depending on the patient's health insurance plan. Eligible commercially insured patients who are prescribed ACTEMRA for an FDA-approved use can receive up to $15,000 in assistance annually for drug costs. See terms and conditions for each program. Program limits apply. - We can refer you to an independent co-pay assistance foundation. This is a charitable organization that may give financial help for medicines§
Not sure what you need?
The Genentech Patient Resource Center can help answer questions and connect you to an appropriate Genentech patient support service.
Call 1-800-ACTEMRA (1-800-228-3672) with questions or to get started.
*If you have health insurance, you should try to get other types of financial assistance, if available. You also need to meet income requirements. If you do not have insurance, or if your insurance does not cover your Genentech medicine, you must meet a different set of income requirements.
‡This ACTEMRA Co-pay Program is valid ONLY for patients with commercial insurance who have a valid prescription for a Food and Drug Administration (FDA)-approved indication of a Genentech medication. Patients using Medicare, Medicaid or any other federal or state government program to pay for their medications are not eligible.
Under the program, the patient will pay a co-pay. After reaching the maximum program benefit, the patient will be responsible for all remaining out-of-pocket expenses. The amount of the program benefit cannot exceed the patients’ out-of-pocket expenses for the cost associated with ACTEMRA.
All participants are responsible for reporting the receipt of all program benefits as required by any insurer or by law. No party may seek reimbursement for all or any part of the benefit received through this Program. The program is only valid in the United States and U.S. Territories. This program is void where prohibited by law and shall follow state restrictions in relation to AB-rated generic equivalents (e.g., MA, CA) where applicable. The patient, guardian, prescriber, hospital and any other person using the program agree not to seek reimbursement for all or any part of the benefit received by the patient through the offer of this program. Genentech reserves the right to rescind, revoke or amend the program without notice at any time. Additional terms and conditions apply. Please visit RACOPAY.COM for the full list of Terms and Conditions.
§Independent co-pay assistance foundations have their own rules for eligibility. Genentech has no involvement or influence in independent foundation decision-making or eligibility criteria and does not know if a foundation will be able to help you. We can only refer you to a foundation that supports your disease state. Genentech does not endorse or show preference for any particular foundation. The foundations we refer you to may not be the only ones that might be able to help you.